Hypopharyngeal Cancer - 25 Studies Found Active, not recruiting : A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab : Oropharyngeal Cancer Hypopharyngeal Cancer Oral Cancer Laryngeal Cancer Hypopha : 2005-09-12 Active, not recruiting : Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia : Head and Neck Cancer Radiation Toxicity Xerostomia : 2004-04-07 : Procedure: management of therapy complications Completed : Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx : Head and Neck Cancer : 2005-10-20 : Drug: docetaxel Radiation: radiation thera Withdrawn : Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence : Head and Neck Cancer : 2010-06-10 : Biological: panitumumab Drug: cisplatin Completed : Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) : Squamous Cell Carcinoma of the Hypopharynx Larynx Carcinoma : 2007-07-27 : Radiation: Radiation Radiation Active, not recruiting : IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC : Oral Cancer Oropharynx Cancer Hypoph : 2005-09-09 : Procedure: IMRT 75 Gy 50 Gy in Terminated : Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers : Larynx Neoplasms : 2005-08-09 : Radiation: Concurrent Chemoradiation Completed : Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx : Head and Neck Cancer : 1999-11-01 : Drug: cisplatin Drug: fluorouracil Completed : Robotic Assisted Surgery in Upper Aerodigestive Tract Surgery : Head and Neck Cancer Oropharyngeal Cancer
